Rudi De Bastiani

Feltre, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Improvement in Chronic Atrophic Gastritis After Treatment with Zinc L-Carnosine.

Improvement in Chronic Atrophic Gastritis After Treatment with Zinc L-Carnosine.

Journal: The American journal of case reports

Published: November 20, 2025

Gut Microbiota May Predict the Short-Term Recurrence of Symptomatic Uncomplicated Diverticular Disease.

Gut Microbiota May Predict the Short-Term Recurrence of Symptomatic Uncomplicated Diverticular Disease.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: September 07, 2025

Impact of Diet on Gut Microbiota in Diverticular Disease of the Colon: An Exploratory Retrospective Study.

Impact of Diet on Gut Microbiota in Diverticular Disease of the Colon: An Exploratory Retrospective Study.

Journal: Microorganisms

Published: August 31, 2025

Gut Microbiota Perturbation Are Linked to Endoscopic Severity of Diverticular Disease.

Gut Microbiota Perturbation Are Linked to Endoscopic Severity of Diverticular Disease.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: May 27, 2025

Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain.

Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain.

Journal: European journal of gastroenterology & hepatology

Published: November 08, 2024

Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease.

Micro-encapsulated and colonic-release sodium butyrate modulates gut microbiota and improves abdominal pain in patients with symptomatic uncomplicated diverticular disease.

Journal: Frontiers in medicine

Published: August 28, 2024

Can gut microbiota explain acute diverticulitis occurrence in patients with symptomatic uncomplicated diverticular disease?

Can gut microbiota explain acute diverticulitis occurrence in patients with symptomatic uncomplicated diverticular disease?

Journal: Bioscience of microbiota, food and health

Published: June 18, 2024

Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care.

Assessment of small intestinal bacterial overgrowth and methane production in patients on chronic proton-pump inhibitor treatment: prevalence and role of rifaximin in its management in primary care.

Journal: Minerva gastroenterology

Published: March 21, 2023

Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.

Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS.

Journal: Journal of clinical medicine

Published: January 30, 2022

General practitioners' management of symptomatic uncomplicated diverticular disease of the colon by using rifaximin, a non-adsorbable antibiotic.

General practitioners' management of symptomatic uncomplicated diverticular disease of the colon by using rifaximin, a non-adsorbable antibiotic.

Journal: European review for medical and pharmacological sciences

Published: January 28, 2021

Elimination of Dietary Triggers Is Successful in Treating Symptoms of Gastroesophageal Reflux Disease.

Elimination of Dietary Triggers Is Successful in Treating Symptoms of Gastroesophageal Reflux Disease.

Journal: Digestive diseases and sciences

Published: March 28, 2020

Usefulness of Pep-Test for Laryngo-Pharyngeal Reflux: A Pilot Study in Primary Care.

Usefulness of Pep-Test for Laryngo-Pharyngeal Reflux: A Pilot Study in Primary Care.

Journal: Korean journal of family medicine

Published: December 31, 2018

Showing 1-12 of 20

Last Updated: 09/26/2026